Cargando…

SHMT2 expression as a diagnostic and prognostic marker for thyroid cancer

BACKGROUND: Catabolism of serine via serine hydroxymethyltransferase2 (SHMT2) through the mitochondrial one-carbon unit pathway is important in tumorigenesis. Therefore, SHMT2 may play a role in thyroid cancer. METHODS: Thyroid tissue samples and The Cancer Genome Atlas (TCGA) database were used to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Meihua, Lee, Woo Kyung, You, Mi-Hyeon, Jang, Ahreum, Cheng, Sheue-yann, Kim, Won Gu, Jeon, Min Ji, Lee, Yu-Mi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240706/ https://www.ncbi.nlm.nih.gov/pubmed/34010151 http://dx.doi.org/10.1530/EC-21-0135

Ejemplares similares

Death-Associated Protein Kinase 1 Inhibits Progression of Thyroid Cancer by Regulating Stem Cell Markers
por: You, Mi-Hyeon, et al.
Publicado: (2021)

Mitofusin-2 modulates the epithelial to mesenchymal transition in thyroid cancer progression
por: You, Mi-Hyeon, et al.
Publicado: (2021)

Immunoglobulin G4-Related Thyroid Disease: A Single-Center Experience and Literature Review
por: Jin, Meihua, et al.
Publicado: (2022)

Graves’ disease diagnosed in remnant thyroid after lobectomy for thyroid cancer
por: Jin, Meihua, et al.
Publicado: (2022)

Targeting transcriptional regulators for treatment of anaplastic thyroid cancer
por: Lee, Woo Kyung, et al.
Publicado: (2021)

SHMT2 Induces Stemness and Progression of Head and Neck Cancer
por: Jin, Yanli, et al.
Publicado: (2022)

SHMT1 and SHMT2 Are Functionally Redundant in Nuclear De novo Thymidylate Biosynthesis
por: Anderson, Donald D., et al.
Publicado: (2009)

Mutation in Genes Encoding Key Functional Groups Additively Increase Mortality in Patients with BRAF(V600E)-Mutant Advanced Papillary Thyroid Carcinoma
por: Song, Eyun, et al.
Publicado: (2021)

Downregulating serine hydroxymethyltransferase 2 (SHMT2) suppresses tumorigenesis in human hepatocellular carcinoma
por: Woo, Chern Chiuh, et al.
Publicado: (2016)

Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells
por: Ji, Lijuan, et al.
Publicado: (2019)

Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors
por: Bernhardt, Stephan, et al.
Publicado: (2017)

Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma
por: Luo, Lianxiang, et al.
Publicado: (2021)

Cancer proteome and metabolite changes linked to SHMT2
por: Tong, Jiefei, et al.
Publicado: (2020)

Diagnostic and Prognostic Markers in Differentiated Thyroid Cancer
por: Gómez Sáez, José M
Publicado: (2011)

Expression of NF2 Modulates the Progression of BRAF(V600E) Mutated Thyroid Cancer Cells
por: You, Mi-Hyeon, et al.
Publicado: (2019)

SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma
por: Ning, Shanglei, et al.
Publicado: (2018)

Oncogenic mutations of thyroid hormone receptor β
por: Park, Jeong Won, et al.
Publicado: (2015)

Epigenetic Modifications: Novel Therapeutic Approach for Thyroid Cancer
por: Zhu, Xuguang, et al.
Publicado: (2017)

Genetic Profiles of Aggressive Variants of Papillary Thyroid Carcinomas
por: Jin, Meihua, et al.
Publicado: (2021)

Metformin blocks progression of obesity-activated thyroid cancer in a mouse model
por: Park, Jeongwon, et al.
Publicado: (2016)

SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia
por: García-Cañaveras, Juan C., et al.
Publicado: (2020)

Metabolic control of BRISC-SHMT2 assembly regulates immune signaling
por: Walden, Miriam, et al.
Publicado: (2019)

Roles of Mitochondrial Serine Hydroxymethyltransferase 2 (SHMT2) in Human Carcinogenesis
por: Zeng, Yuanyuan, et al.
Publicado: (2021)

Glycyrrhetinic acid restricts mitochondrial energy metabolism by targeting SHMT2
por: Jin, Xiuxiu, et al.
Publicado: (2022)

Recent Changes in the Incidence of Thyroid Cancer in Korea between 2005 and 2018: Analysis of Korean National Data
por: Choi, Yun Mi, et al.
Publicado: (2022)

Standardized Thyroid Cancer Mortality in Korea between 1985 and 2010
por: Choi, Yun Mi, et al.
Publicado: (2014)

Association between thyroid autoimmunity and Helicobacter pylori infection
por: Choi, Yun Mi, et al.
Publicado: (2017)

Genetic Alterations in Medullary Thyroid Cancer: Diagnostic and Prognostic Markers
por: A, Taccaliti, et al.
Publicado: (2011)

SUN-338 Inflammation Promotes Aggressive Thyroid Cancer Progression in a Mouse Model
por: Park, Sunmi, et al.
Publicado: (2019)

Tumor Cells and Cancer-Associated Fibroblasts: A Synergistic Crosstalk to Promote Thyroid Cancer
por: Fozzatti, Laura, et al.
Publicado: (2020)

SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling
por: Wang, Weida, et al.
Publicado: (2023)

Long-term follow-up result of antithyroid drug treatment of Graves’ hyperthyroidism in a large cohort
por: Jin, Meihua, et al.
Publicado: (2023)

Synergistic Signaling of KRAS and Thyroid Hormone Receptor β Mutants Promotes Undifferentiated Thyroid Cancer through MYC Up-Regulation()()
por: Zhu, Xuguang, et al.
Publicado: (2014)

SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer
por: Komlósi, Viktor, et al.
Publicado: (2010)

Metformin Is a Pyridoxal-5′-phosphate (PLP)-Competitive Inhibitor of SHMT2
por: Tramonti, Angela, et al.
Publicado: (2021)

SHMT2 Drives the Progression of Colorectal Cancer by Regulating UHRF1 Expression
por: Cui, Ximao, et al.
Publicado: (2022)

FLOURY ENDOSPERM20 encoding SHMT4 is required for rice endosperm development
por: Yan, Mengyuan, et al.
Publicado: (2022)

Understanding The Regulatory Role of USP32 and SHMT2 in The Progression of Gastric Cancer
por: Li, Jun, et al.
Publicado: (2023)

HDAC11 regulates type I interferon signaling through defatty-acylation of SHMT2
por: Cao, Ji, et al.
Publicado: (2019)

Serum vitamin D3 levels are not associated with thyroid cancer prevalence in euthyroid subjects without autoimmune thyroid disease
por: Choi, Yun Mi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_udnnjqevmi7eb6tmgojp7kq1id